Planning

Cancer Vaccine Launchpad (CVLP)

NHS ENGLAND

This public procurement record has 1 release in its history.

Planning

04 Oct 2023 at 10:48

Summary of the contracting process

The NHS England is seeking a supplier for the Cancer Vaccine Launchpad (CVLP) project, aimed at facilitating access to personalised cancer vaccine research trials in collaboration with various healthcare and research organisations. The procurement stage is currently at the planning phase, with a scheduled event on October 17th, 2023, from 9:30 am to 11:00 am. The estimated contract value is £1,400,000, with a duration of 15 months starting from January 1st, 2024, to March 31st, 2025. The project is in the services category within the health industry.

The Cancer Vaccine Launchpad (CVLP) tender presents an opportunity for businesses to provide digital infrastructure and clinical liaison services to manage the end-to-end pathway for up to 2000 patients until March 2025. Suitable businesses with expertise in healthcare technology and clinical support functions are well-suited to compete for this tender. Interested parties can register for the event on October 17th, 2023, to engage with NHS England representatives and learn more about the project requirements and opportunities for collaboration.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Cancer Vaccine Launchpad (CVLP)

Notice Description

You are invited to attend a virtual market engagement for the Cancer Vaccine Launch Pad (CVLP).<br/><br/>Overview<br/>The CVLP is a strategic priority and collaboration between NHS England, the Department of Health and Social Care (DHSC), the Office for Life Sciences (OLS), the National Institute of Health Research (NIHR) and Genomics England (GEL), with the aim to facilitate access to personalised cancer vaccine research trials. The project was jointly announced in July 2023 with the Secretary of State and in partnership with the Prime Minister. See link (https://www.gov.uk/government/news/major-agreement-to-deliver-new-cancer-vaccine-trials#:~:text=It%20will%20work%20by%20creating,become%20part%20of%20standard%20care)<br/><br/>Through the CVLP platform, cancer patients from across a network of up to 140 NHS cancer care providers will be asked to consent to be put forward for clinical trials. Their surplus tissue samples, obtained through standard of care pathways, will be used to assess their eligibility. The detail of any available trials will be shared with the participant and their treating clinical team to see if the patient wishes to take part, and if so, the patient will travel to the nearest trial site to access the clinical trial.<br/><br/>The CVLP is company agnostic and is being set up in a phased approach with a small number of Trusts to test the pathway from September 2023. For the first phase, the CVLP is supporting one cancer vaccine clinical trial. It is likely that three to four additional trials will be brought into the CVLP during 2024.<br/><br/>NHS England is looking for a supplier to provide the digital infrastructure and clinical liaison function to manage the end-to-end pathway of the CVLP for up to 2000 patients until March 2025.<br/><br/>Estimated spend (excl. VAT): PS1,400,000<br/><br/>Estimated Duration: 15 months<br/><br/>Contract duration:<br/>Proposed contract start date: 01/01/2024<br/>Proposed contract end date: 31/03/2025<br/><br/>Date of event: October 17th, 2023, 9.30am - 11:00am<br/><br/>Attendees are limited to 2 per company. To register your interest please contact england.cancervaccinelaunchpad@nhs.net and state the names and titles of those intending to attend.<br/><br/>Thank you.

Lot Information

Lot 1

PIN notice only for market engagement. Details contained in the short description. Additional information: N/A

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0407c8
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/029235-2023
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85100000 - Health services

Notice Value(s)

Tender Value
£1,400,000 £1M-£10M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
4 Oct 20232 years ago
Submission Deadline
Not specified
Future Notice Date
19 Oct 2023Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Contact Name
NHSE Commercial Team
Contact Email
england.cancervaccinelaunchpad@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Post Town
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0407c8-2023-10-04T11:48:54+01:00",
    "date": "2023-10-04T11:48:54+01:00",
    "ocid": "ocds-h6vhtk-0407c8",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-0407c8",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Cancer Vaccine Launchpad (CVLP)",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "85100000",
            "description": "Health services"
        },
        "mainProcurementCategory": "services",
        "description": "You are invited to attend a virtual market engagement for the Cancer Vaccine Launch Pad (CVLP).<br/><br/>Overview<br/>The CVLP is a strategic priority and collaboration between NHS England, the Department of Health and Social Care (DHSC), the Office for Life Sciences (OLS), the National Institute of Health Research (NIHR) and Genomics England (GEL), with the aim to facilitate access to personalised cancer vaccine research trials. The project was jointly announced in July 2023 with the Secretary of State and in partnership with the Prime Minister. See link (https://www.gov.uk/government/news/major-agreement-to-deliver-new-cancer-vaccine-trials#:~:text=It%20will%20work%20by%20creating,become%20part%20of%20standard%20care)<br/><br/>Through the CVLP platform, cancer patients from across a network of up to 140 NHS cancer care providers will be asked to consent to be put forward for clinical trials. Their surplus tissue samples, obtained through standard of care pathways, will be used to assess their eligibility. The detail of any available trials will be shared with the participant and their treating clinical team to see if the patient wishes to take part, and if so, the patient will travel to the nearest trial site to access the clinical trial.<br/><br/>The CVLP is company agnostic and is being set up in a phased approach with a small number of Trusts to test the pathway from September 2023. For the first phase, the CVLP is supporting one cancer vaccine clinical trial. It is likely that three to four additional trials will be brought into the CVLP during 2024.<br/><br/>NHS England is looking for a supplier to provide the digital infrastructure and clinical liaison function to manage the end-to-end pathway of the CVLP for up to 2000 patients until March 2025.<br/><br/>Estimated spend (excl. VAT): PS1,400,000<br/><br/>Estimated Duration: 15 months<br/><br/>Contract duration:<br/>Proposed contract start date: 01/01/2024<br/>Proposed contract end date: 31/03/2025<br/><br/>Date of event: October 17th, 2023, 9.30am - 11:00am<br/><br/>Attendees are limited to 2 per company. To register your interest please contact england.cancervaccinelaunchpad@nhs.net and state the names and titles of those intending to attend.<br/><br/>Thank you.",
        "value": {
            "amount": 1400000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "PIN notice only for market engagement. Details contained in the short description. Additional information: N/A",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2023-10-20T00:00:00+01:00",
            "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
        }
    },
    "parties": [
        {
            "id": "GB-FTS-3022",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Quarry House, Quarry Hill",
                "locality": "Leeds",
                "region": "UK",
                "postalCode": "LS2 7UE",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "NHSE Commercial Team",
                "email": "england.cancervaccinelaunchpad@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk/",
                "buyerProfile": "https://www.england.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-3022",
        "name": "NHS England"
    },
    "language": "en"
}